At the annual AWS Life Sciences Executive Symposium, the company announced new Amazon Omics capabilities to help customers build, run and scale 35 Ready2Run workflows by Element Biosciences, NVIDIA and Sentieon Inc.
WHY IT MATTERS
Large-scale analysis omics data typically requires specialized bioinformatics workflows to process data sets.
For use cases where customers want to run industry-standard analysis workflows without any…